MiNK Therapeutics, Inc. INKT on Nasdaq
This company's Exchange Act registration has been revoked
This company's Exchange Act registration as a Municipal Advisor has been revoked
This company's Exchange Act registration as a Municipal Advisor has been cancelled
[+] Company Information
CIK:
0001840229
0001840229
EIN:
LEI:
(CF Office: 03 Life Sciences)
Business address:
149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
Phone: 212-994-8250
149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
Phone: 212-994-8250
Mailing address:
149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
Category:
Emerging growth company
Emerging growth company
Former names:
- AgenTus Therapeutics, Inc. - filings through 2021-03-18
- AgenTus Therapeutics, Inc. - filings through 2021-03-18
Filings:
184 EDGAR filings since January 22, 2021
184 EDGAR filings since January 22, 2021
Get insider transactions
for this issuer
Get insider transactions
for this reporting owner
Latest Filings (excluding insider transactions)
- March 18, 2025 - 10-K: Annual report for year ending December 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- March 18, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 2.02 - Results of Operations and Financial Condition
- 9.01 - Financial Statements and Exhibits
- January 21, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 5.03 - Amendments to Articles of Incorporation or Bylaws Change in Fiscal Year
- 5.07 - Submission of Matters to a Vote of Security Holders
- 9.01 - Financial Statements and Exhibits
- December 20, 2024 - DEF 14A: Other definitive proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
- December 6, 2024 - PRE 14A: Other preliminary proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
Selected Filings
[+] 8-K (current reports)
- March 18, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 2.02 - Results of Operations and Financial Condition
- 9.01 - Financial Statements and Exhibits
- January 21, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 5.03 - Amendments to Articles of Incorporation or Bylaws Change in Fiscal Year
- 5.07 - Submission of Matters to a Vote of Security Holders
- 9.01 - Financial Statements and Exhibits
[+] 10-K (annual reports) and 10-Q (quarterly reports)
- March 18, 2025 - 10-K: Annual report for year ending December 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- November 14, 2024 - 10-Q: Quarterly report for quarter ending September 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- August 13, 2024 - 10-Q: Quarterly report for quarter ending June 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- May 14, 2024 - 10-Q: Quarterly report for quarter ending March 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Proxy (annual meeting) and information statements
- December 20, 2024 - DEF 14A: Other definitive proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
- December 6, 2024 - PRE 14A: Other preliminary proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
- April 29, 2024 - DEF 14A: Other definitive proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Ownership disclosures
- Insider transactions
- March 5, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- March 5, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- March 5, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- Beneficial ownership (Schedule 13D and 13G)
- May 22, 2024 - SC 13G: Statement of acquisition of beneficial ownership by individuals Open documentClick to Open document FilingOpen filingClick to Open filing
Filings
| Form type | Form description | Filing date | Reporting date |
|---|
0
Showing 1 to 15 of 184 entries
Data source:
CIK0001840229.json
There is no filings data for
this organization
Investor Resources
How to Use EDGAR
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more.
Before you Invest, Investor.gov
Get answers to your investing questions from the SEC's website dedicated to retail investors
